Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
This post appeared first on investingnews.com
Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets
Download the PDF here.
Laramide Resources (TSX:LAM,ASX:LAM,OTCQX:LMRXF) announced that it has identified multiple target ...
Coinbase Global (NASDAQ:COIN) said on Tuesday (September 16) that it ...
NVIDIA’s (NASDAQ:NVDA) new RTX6000D chip, built to comply with US ...